26 Chinese hamster ovary (CHO) cells are the most prevalent mammalian cell factories for producing 27 recombinant therapeutic proteins due to their ability to synthesize human-like post-translational 28 modifications and ease of maintenance in suspension cultures. Currently, a wide variety of CHO 29 host cell lines have been developed; substantial differences exist in their phenotypes even when 30 transfected with the same target vector. However, relatively less is known about the influence of 31 their inherited genetic heterogeneity on phenotypic traits and production potential from the 32 bioprocessing point of view. Herein, we present a global transcriptome and proteome profiling of 33 three commonly used parental cell lines (CHO-K1, CHO-DXB11 and CHO-DG44) in suspension 34 cultures and further report their growth-related characteristics, and N-and O-glycosylation 35 patterns of host cell proteins (HCPs). The comparative multi-omics analysis indicated that some 36 physiological variations of CHO cells grown in the same media are possibly originated from the 37 genetic deficits, particularly in the cell cycle progression. Moreover, the dihydrofolate reductase 38 deficient DG44 and DXB11 possess relatively less active metabolism when compared to K1 cells. 39 The protein processing abilities and the N-and O-glycosylation profiles also differ significantly 40 across the host cell lines, suggesting the need to select host cells in a rational manner for the cell 41 line development on the basis of recombinant protein being produced. 42 43
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Abstract 26 Chinese hamster ovary (CHO) cells are the most prevalent mammalian cell factories for producing 27 recombinant therapeutic proteins due to their ability to synthesize human-like post-translational 28 modifications and ease of maintenance in suspension cultures. Currently, a wide variety of CHO 29 host cell lines have been developed; substantial differences exist in their phenotypes even when 30 transfected with the same target vector. However, relatively less is known about the influence of 31 their inherited genetic heterogeneity on phenotypic traits and production potential from the 32 bioprocessing point of view. Herein, we present a global transcriptome and proteome profiling of 33 three commonly used parental cell lines (CHO-K1, CHO-DXB11 and CHO-DG44) in suspension 34 cultures and further report their growth-related characteristics, and N-and O-glycosylation 35 patterns of host cell proteins (HCPs). The comparative multi-omics analysis indicated that some 36 physiological variations of CHO cells grown in the same media are possibly originated from the 37 genetic deficits, particularly in the cell cycle progression. Moreover, the dihydrofolate reductase 38 deficient DG44 and DXB11 possess relatively less active metabolism when compared to K1 cells. 39 The protein processing abilities and the N-and O-glycosylation profiles also differ significantly 40 across the host cell lines, suggesting the need to select host cells in a rational manner for the cell 41 line development on the basis of recombinant protein being produced. recombinant glycoprotein therapeutics due to their humanized post-translational modifications, i.e. 48 N-glycosylation and appropriate protein folding, and the ability to secrete the product naturally 49 outside of the cell (Wurm, 2004) . Among several mammalian host cells, Chinese hamster ovary 50 (CHO) cells are commonly used since they can grow in suspension culture with chemically defined 51 media, and are highly resistant to viral susceptibility. Overall, 84% of the biopharmaceutical drugs 52 are currently produced using CHO cells (Walsh, 2018) . 53 Generally, bioprocess development includes two major stages: 1) establishment of efficient 54 cell lines producing target proteins, and 2) development of optimal cell culture media and/or 55 process conditions (Hong et al., 2018) . Currently, a multitude of CHO cells with various genetic 56 backgrounds have been utilized since the first approval of a drug produced in CHO cells in 1984 57 (Kaufman et al., 1985) . Of them, the CHO-K1, -DXB11 and -DG44 are the most relevant parental 58 cell lines to manufacture target products industrially (Golabgir et al., 2016) . Historically, the 59 proline-deficient K1 cells was established in 1968 (Kao and Puck, 1968), about 10 years after its 60 first isolation from the Chinese hamster ovaries. Later, the DXB11 was generated by mutagenesis 61 targeting the dihydrofolate reductase gene (Dhfr) from K1 cells, resulting in missense mutation in 62 one allele and complete deletion in the other (Urlaub and Chasin, 1980 ; Figure 1a ). Note that the 63 Dhfr gene is responsible for reducing folate, which is an essential step in nucleotide biosynthesis. 64 Even though both alleles of the Dhfr gene were modified in the -DXB11 cells, it still presented 65 some minor activity of the gene. Thus, the deletion of both alleles of this gene led to the generation 66 of the -DG44 cell line in the mid-1980s (Urlaub et al., 1983) . Here, it should be noticed that DG44 67 was not derived from the K1 cell line, but from the very first isolated CHO cell lines (Figure 1a) . 
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Therefore, it is highly required to understand the diversity in the phenotypes of CHO cells and 82 associate it with known genetic heterogeneity for the rational selection of suitable parental cells. 83 Moreover, the characterization of N-and O-glycosylation preferences of various CHO host cells 84 is a critical aspect within the "Quality by Design (QbD)" framework (Butler and Spearman, 2014). 85 Towards the goal of unraveling the heterogeneity of the various CHO parental cell lines 86 and linking it with their genetic diversity, here we have accomplished an integrative multi-omics 87 analysis, at the transcriptomic, proteomic and glycomic levels, of the K1, DG44 and DXB11 cells 88 during the exponential growth phase in suspension cultures. To our knowledge, although a recent 89 study reported proteomics analysis to compare the differential protein expression in CHO-K1, -S 90 and Dhfr − cell lines (Xu et al., 2017) , the current work provides more comprehensive multi-omics Bioanalyzer 2100 (Agilent Technologies, USA). cDNA targets were generated from 250 ng total 119 RNA using the GeneChip 3' IVT PLUS Reagent Kit (Thermo Fisher Scientific). The targets were 120 then hybridized onto a proprietary CHO 3' IVT microarray (CHO V3) consisting of 43,856 probe 121 sets that correspond to 13,358 mouse genes based on CHO EST Sequence and Annotation Release 122 06 (Affymetrix, Singapore). Quality assessment and data analysis were carried out on the CEL 123 files obtained, using Partek Genomics Suite version 6.6 (Partek Inc., USA). 
where N is the total number of genes in CHO cells, K is the total number of up/downregulated 230 genes, n is the total number of genes in pathway "x" and k is the number of up/downregulated 231 genes in pathway "x". The pathway with lowest p-value is classified as highly enriched in 232 differentially expressed genes. 
CHO-K1 grows faster in suspension batch cultures than DG44 and DXB11
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The three CHO parental cell lines, i.e. K1, DG44 and DXB11, were propagated in duplicates in 244 the same DMEM/F12-based protein free chemically defined medium (PFCDM) supplemented 245 with Soybean peptone and HT supplement, in order to reduce variability due to differences in cell 246 culture media. These cell culture experiments clearly showed that the K1 cells grew much faster 247 when compared to the other two cell lines, reaching the maximum cell densities first (Figure 1b) . 248 The doubling time of K1 cells is 20±1 hr whereas DG44 and DXB11 correspond to 30±0.3 and 249 12 32±4, respectively. Notably, these results were highly consistent with an earlier study which 250 reported that the maximum viable cell densities achieved in batch culture following the order of 251 K1>>DG44>DXB11 (Sommeregger et al., 2013). While the cells were grown in commercial 252 media in the earlier study, the concordance between the two results highlight that the slow growth 253 of Dhfr¯ cells is mainly because of the genetic divergence. Here, it should be highlighted that 254 although all the three media contained HT, the purine supplements enabling the cells to overcome 255 deprivation of nucleoside precursors as a result of the Dhfr deficiency, we still observed much 256 lower growth rates than K1. This confirms that the loss of Dhfr gene activity could not be simply 257 compensated by supplementing HT as there could be additional pathways contributing to such 258 growth differences (Florin et al., 2011). In order to further investigate metabolic traits of CHO host 259 cells, we also profiled the major nutrients and byproducts in the cell culture. Glucose was rapidly 260 consumed in the K1 compared to others (Figure 1c) . Similarly, a sharper decrease in the glutamine 261 concentrations was also observed in K1 cell cultures with a concomitant higher accumulation of 262 ammonia and lactate than DXB11 and DG44 cell cultures (Figure 1d) , possibly indicating that K1 263 cells undergo higher carbon and nitrogen catabolism. (Figure 2b and 2c) , highlighting that the 282 genetic divergence of the CHO parental cell lines indeed influences the phenotype via 283 transcriptional and translational regulations. The hierarchical clustering of transcriptome and 284 proteome also showed similar trends, where the global expression patterns of K1 are closer to 285 DXB11 than DG44 cells at both transcript and protein levels (Figure 2d and 2e) , recapitulating 286 the known genetic divergence of the CHO parental cell lines (Figure 1a) . related genes, we also found that the purine nucleotide metabolic processes (as expected, due to 309 the Dhfr gene copy number differences) and sterol metabolic process to be significantly enriched 310 in the differentially expressed genes. Remarkably, the expression patterns of glycosylated protein 311 processing processes such as N-glycosylation, Golgi organization, vesicle-mediated protein 312 transport and protein folding were also significantly altered across cell lines. 313 We next overlaid the transcriptomic and proteomic expression patterns to compare their 314 concordance in each comparison (Figure 3b) 333 However, despite the moderate correlation, we were able to identify a list of 109 genes from such 334 comparisons as potential targets for cellular engineering in CHO cells since they showed a very 335 good correlation in expression between transcript and protein levels (R 2 > 0.9; Supplementary 336 file). (Figure 4c) . On the other hand, the levels 397 of metabolites that are associated with cellular stress and growth inhibition such as oxidized 398 glutathione and CDP-choline were observed to be higher in DG44 (Supplementary file) . abundances revealed several interesting aspects. The initial processing in ER is not likely to be 410 19 different among the cell lines; the high mannose structures were found to be relatively similar. 411 However, there exists an appreciable difference in downstream processing of N-glycans. The 412 terminal GlcNAc containing hybrid structures processed at the cis-Golgi were slightly higher in 413 DXB11 than other two cell lines while the complex tri-antennary structures which are processed 414 in medial-and trans-Golgi were higher in DG44 and K1 (Figure 5a) . Notably, K1 cells had much 415 higher final capping of glycan species, i.e. sialylation, beyond which no further sugar moieties can 416 be added. Apart from N-glycans, we also measured the relative abundances of O-glycans including 417 three major structures, T antigen, sialyl-T antigen and diasialyl-T antigen. Further, the sialylated 418 structures were found to be more abundant in K1 than the other two cell lines even in O-glycans 419 (Figure 5b) . 420 We subsequently correlated the variations in N-glycan species with the transcriptomic and 421 proteomic data of the N-glycosylation associated pathways (Figure 5c) 
Hard-wired changes of gene expression in signaling and nucleotide metabolic pathways
